Stephen Huang
Executive Director Clinical Biomarkers & Companion Diagnostics Avenzo Therapeutics
Seminars
Tuesday 13th October 2026
From Biology to the Clinic: Optimizing Rationale, Development & Translation of Bispecific ADCs
2:00 pm
- Breaking down biology rationale for pursuing bispecific ADC development and selecting target pairings
- Evaluating preclinical profiles of bispecific ADCs highlighting favorable efficacy and tolerability profiles against monospecific therapies
- Laying out considerations and strategy to optimize successful translational through biomarker and clinical development strategies
